"The retina specialists and surgeons of Retina Consultants of Minnesota provide advanced care to patients throughout Minnesota. Visit our retina center in Edina, MN for treatment of macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, macular edema, macular hole, uveitis, and more. We provide retinal diagnostic testing such as fluorescein angiography. Our treatments include eye injections (Avastin, Eylea, Lucentis), vitrectomy, and scleral buckle. We also participate in many retina clinical trials through our retina research center. Our locations in the Minneapolis-St. Paul Twin City area are easily accessible for patients in Edina, Blaine, Plymouth, St. Cloud, Woodbury, Bloomington, Eagan, Duluth, and beyond."

During the past decade, Retina Center PA conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Center PA" #1 sponsor was "Jaeb Center for Health Research" with 13 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored and "Apellis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Center PA" #1 collaborator was "National Eye Institute (NEI)" with 13 trials as a collaborator, "Allergan" with 4 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Retina Center PA" are "Diabetic Macular Edema" (11 trials), "Diabetic Retinopathy" (8 trials), "Proliferative Diabetic Retinopathy" (3 trials), "Vitreous Hemorrhage" (3 trials) and "Central Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Retina Center PA" in a lesser frequency.

Most popular intervention types in "Retina Center PA" are "Drug" (27 trials), "Procedure" (10 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (3 trials), "Ranibizumab" (3 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Center PA" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Retina Center PA". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Retina Center PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Center PA, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Retina Center PA has several departments that took part in Clinical trials: "Vitreoretinal Surgery" - 15 trials